BioCentury
ARTICLE | Product Development

Biotech not discouraged by Merck protease inhibitor setback

February 28, 1994 8:00 AM UTC

Biotech not discouraged by Merck protease inhibitor setback

The biotech contenders in the HIV protease inhibitor race haven't been discouraged by recent reports that virus levels in patients treated with Merck's L-735,524 compound have returned to baseline levels. ...